Overuse of digital gadgets harms teenagers, research suggests. But ubiquitous technology may be helping older Americans stay sharp.

Kentucky Gov. Andy Beshear, a Democrat, announced Monday that bromazolam, aka "Designer Xanax," has been reclassified as a Schedule 1 drug. Other states making news: Connecticut, North Carolina, ...

Health and Human Services Secretary Robert F. Kennedy Jr. is targeting the government’s Vaccine Injury Compensation Program, without which manufacturers might cease producing shots.

Meanwhile, Iowa Medicaid work requirements are set to go into effect in January. Also: the impact of Medicaid cuts on Black children; provider reimbursement rate cuts in North Carolina; and more.

Although there are no specific FDA-approved drugs in the U.S. to treat the parasite, the emergency authorization paves the way for the use of animal drug products approved for other purposes or ...

A report by the Business Group on Health showing health care costs projected to rise 9% in 2026 has caused companies to reevaluate benefits and contracts for the coming year. A survey shows 66% of ...

The system, from Signos, offers three- and six-month plans ($139 and $129 a month, respectively), and the company will send all of the continuous glucose monitors a patient needs, CNBC reported. Plus: ...

In a Goliath-versus-David fight, UnitedHealth Group’s pharmacy benefit manager, Optum Rx, has filed lawsuits in five counties ...

La región es una de las más pobres del estado. En el condado de Alamosa, 2 de cada 5 residentes están inscritos en Health ...

The American Academy of Pediatrics' recommendation is for children ages 6 to 23 months. In May, HHS Secretary Robert F. Kennedy Jr. removed the covid vaccine from the CDC's immunization schedule for ...

As Modern Healthcare reported, a rush of people left uninsured because of Medicaid cuts and/or ACA changes could overwhelm already packed emergency departments and hospitals. Community health workers ...

We do believe that people who face high out-of-pocket costs need more options,” said Kevin Donahoe, diabetes marketing chief for Novo Nordisk. Plus: a look at the drugmaker's alliance with GoodRx; how ...